American Academy of Periodontology best evidence consensus statement on the use of biologics in clinical practice
dc.contributor.author | Avila-Ortiz, Gustavo | |
dc.contributor.author | Ambruster, Jeanne | |
dc.contributor.author | Barootchi, Shayan | |
dc.contributor.author | Chambrone, Leandro | |
dc.contributor.author | Chen, Chia-Yu | |
dc.contributor.author | Dixon, Douglas R. | |
dc.contributor.author | Geisinger, Maria L. | |
dc.contributor.author | Giannobile, William V. | |
dc.contributor.author | Goss, Katie | |
dc.contributor.author | Gunsolley, John C. | |
dc.contributor.author | Heard, Rick H. | |
dc.contributor.author | Kim, David M. | |
dc.contributor.author | Mandelaris, George A. | |
dc.contributor.author | Monje, Alberto | |
dc.contributor.author | Nevins, Marc L. | |
dc.contributor.author | Palaiologou-Gallis, Angela | |
dc.contributor.author | Rosen, Paul S. | |
dc.contributor.author | Scheyer, E. Todd | |
dc.contributor.author | Suarez-Lopez Del Amo, Fernando | |
dc.contributor.author | Tavelli, Lorenzo | |
dc.contributor.author | Velasquez, Diego | |
dc.contributor.author | Wang, Hom-Lay | |
dc.contributor.author | Mealey, Brian L. | |
dc.date.accessioned | 2023-01-11T16:24:29Z | |
dc.date.available | 2024-01-11 11:24:27 | en |
dc.date.available | 2023-01-11T16:24:29Z | |
dc.date.issued | 2022-12 | |
dc.identifier.citation | Avila-Ortiz, Gustavo ; Ambruster, Jeanne; Barootchi, Shayan; Chambrone, Leandro; Chen, Chia-Yu ; Dixon, Douglas R.; Geisinger, Maria L.; Giannobile, William V.; Goss, Katie; Gunsolley, John C.; Heard, Rick H.; Kim, David M.; Mandelaris, George A.; Monje, Alberto; Nevins, Marc L.; Palaiologou-Gallis, Angela ; Rosen, Paul S.; Scheyer, E. Todd; Suarez-Lopez Del Amo, Fernando ; Tavelli, Lorenzo; Velasquez, Diego; Wang, Hom-Lay ; Mealey, Brian L. (2022). "American Academy of Periodontology best evidence consensus statement on the use of biologics in clinical practice." Journal of Periodontology 93(12): 1763-1770. | |
dc.identifier.issn | 0022-3492 | |
dc.identifier.issn | 1943-3670 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/175460 | |
dc.description.abstract | A biologic is a therapeutic agent with biological activity that is administered to achieve an enhanced regenerative or reparative effect. The use of biologics has progressively become a core component of contemporary periodontal practice. However, some questions remain about their safety, indications, and effectiveness in specific clinical scenarios. Given their availability for routine clinical use and the existing amount of related evidence, the goal of this American Academy of Periodontology (AAP) best evidence consensus (BEC) was to provide a state-of-the-art, evidence-based perspective on the therapeutic application of autologous blood-derived products (ABPs), enamel matrix derivative (EMD), recombinant human platelet-derived growth factor BB (rhPDGF-BB), and recombinant human bone morphogenetic protein 2 (rhBMP-2). A panel of experts with extensive knowledge on the science and clinical application of biologics was convened. Three systematic reviews covering the areas of periodontal plastic surgery, treatment of infrabony defects, and alveolar ridge preservation/reconstruction and implant site development were conducted a priori and provided the foundation for the deliberations. The expert panel debated the merits of published data and exchanged experiential information to formulate evidence-based consensus statements and recommendations for clinical practice and future research. Based on an analysis of the current evidence and expert opinion, the panel concluded that the appropriate use of biologics in periodontal practice is generally safe and provides added benefits to conventional treatment approaches. However, therapeutic benefits and risks range based on the specific biologics used as well as patient-related local and systemic factors. Given the limited evidence available for some indications (e.g., gingival augmentation therapy, alveolar ridge preservation/reconstruction, and implant site development), future clinical studies that can expand the knowledge base on the clinical use of biologics in periodontal practice are warranted. | |
dc.publisher | Wiley Periodicals, Inc. | |
dc.publisher | Quintessence Publishing | |
dc.subject.other | alveolar ridge preservation | |
dc.subject.other | biologics | |
dc.subject.other | implant site development | |
dc.subject.other | periodontal plastic surgery | |
dc.subject.other | periodontal therapy | |
dc.subject.other | periodontal regeneration | |
dc.title | American Academy of Periodontology best evidence consensus statement on the use of biologics in clinical practice | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Dentistry | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/175460/1/jper11030_am.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/175460/2/jper11030.pdf | |
dc.identifier.doi | 10.1002/JPER.22-0361 | |
dc.identifier.source | Journal of Periodontology | |
dc.identifier.citedreference | Kao RT, Curtis DA, Kim DM, et�al. American Academy of Periodontology best evidence consensus statement on modifying periodontal phenotype in preparation for orthodontic and restorative treatment. J Periodontol. 2020; 91: 289 - 298. | |
dc.identifier.citedreference | Mandelaris GA, Scheyer ET, Evans M, et�al. American Academy of Periodontology best evidence consensus statement on selected oral applications for cone-beam computed tomography. J Periodontol. 2017; 88: 939 - 945. | |
dc.identifier.citedreference | Su�rez-L�pez del Amo F, Monje A. Efficacy of biologics for alveolar ridge preservation/reconstruction and implant site development: an American Academy of Periodontology best evidence systematic review. J Periodontol. 2022; 93: 1827 - 1847. | |
dc.identifier.citedreference | Chambrone L, Botelho J, Machado V, Mascarenhas P, Mendes JJ, Avila-Ortiz G. Does the subepithelial connective tissue graft in conjunction with a coronally advanced flap remain as the gold standard therapy for the treatment of single gingival recession defects? A systematic review and network meta-analysis. J Periodontol. 2022; 93: 1336 - 1352. | |
dc.identifier.citedreference | Cairo F, Nieri M, Cincinelli S, Mervelt J, Pagliaro U. The interproximal clinical attachment level to classify gingival recessions and predict root coverage outcomes: An explorative and reliability study. J Clin Periodontol. 2011; 38: 661 - 666. | |
dc.identifier.citedreference | Chambrone L, Avila-Ortiz G. An evidence-based system for the classification and clinical management of non-proximal gingival recession defects. J Periodontol. 2021; 92: 327 - 335. | |
dc.identifier.citedreference | Tavelli L, Chen C-Y, Barootchi S, Kim DM. Efficacy of biologics for the treatment of periodontal infrabony defects: an American Academy of Periodontology best evidence systematic review and network meta-analysis. J Periodontol. 2022; 93: 1803 - 1826. | |
dc.identifier.citedreference | Chambrone L, Barootchi S, Avila-Ortiz G. Efficacy of biologics in root coverage and gingival augmentation therapy: An American Academy of Periodontology best evidence systematic review and network meta-analysis. J Periodontol. 2022; 93: 1771 - 1802. | |
dc.identifier.citedreference | Larsson L, Decker AM, Nibali L, Pilipchuk SP, Berglundh T, Giannobile WV. Regenerative medicine for periodontal and peri-implant diseases. J Dent Res. 2016; 95: 255 - 266. | |
dc.identifier.citedreference | Chambrone L, Avila-Ortiz G, eds. TISSUES: Critical Issues in Periodontal and Implant-Related Plastic and Reconstructive Surgery. Quintessence Publishing; 2022. | |
dc.identifier.citedreference | FDA Code of Federal Regulations Title 21 -. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=600.3 | |
dc.identifier.citedreference | Avila-Ortiz G, Bartold PM, Giannobile W, et�al. Biologics and cell therapy tissue engineering approaches for the management of the edentulous maxilla: A systematic review. Int J Oral Maxillofac Implants. 2016 ( 31 ): s121 - 164. Suppl. | |
dc.identifier.citedreference | American Academy of Periodontology. Comprehensive periodontal therapy: A statement by the American Academy of Periodontology. J Periodontol 2011; 82: 943 - 949. | |
dc.identifier.citedreference | Mills MP, Rosen PS, Chambrone L, et�al. American Academy of Periodontology best evidence consensus statement on the efficacy of laser therapy used alone or as an adjunct to non-surgical and surgical treatment of periodontitis and peri-implant diseases. J Periodontol. 2018; 89: 737 - 742. | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.